Showing results (251-260 of 272) with videos related to

Sort By:
Pageof 28
Arthritis Research & Therapy|April 26, 2012
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosisLara Bossini-Castillo, Carmen P Simeon, Lorenzo Beretta, et al.
Thorax|March 6, 2024
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseasesLeticia Kawano-Dourado, Tejaswini Kulkarni, Christopher J Ryerson, et al.
The Journal of Rheumatology|July 3, 2017
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic SclerosisLara Bossini-Castillo, Diana Campillo-Davó, Elena López-Isac, et al.
Annals of the Rheumatic Diseases|January 18, 2026
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)Liubov Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, et al.
Journal of the American Heart Association|February 26, 2025
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research CohortAndrea-Hermina Györfi, Tim Filla, Amin Polzin, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Annals of the Rheumatic Diseases|April 11, 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyMuriel Elhai, Marouane Boubaya, Oliver Distler, et al.
Annals of the Rheumatic Diseases|August 17, 2012
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication studyLara Bossini-Castillo, Jose Ezequiel Martin, Jasper Broen, et al.
Rheumatology (Oxford, England)|August 31, 2011
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European populationLara Bossini-Castillo, Carmen P Simeon, Lorenzo Beretta, et al.
Pageof 28